X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1149) 1149
index medicus (1097) 1097
female (1042) 1042
breast cancer (876) 876
cancer (832) 832
oncology (795) 795
middle aged (750) 750
breast neoplasms - pathology (654) 654
adult (627) 627
aged (605) 605
prognosis (568) 568
breast neoplasms - mortality (471) 471
tumors (410) 410
medicine & public health (329) 329
diagnosis (323) 323
pathology (317) 317
neoplasms (316) 316
neoplasm staging (311) 311
aged, 80 and over (287) 287
breast neoplasms - genetics (255) 255
carcinoma (243) 243
survival (236) 236
surgery (232) 232
immunohistochemistry (229) 229
breast neoplasms - metabolism (217) 217
therapy (209) 209
risk factors (208) 208
research (202) 202
breast (197) 197
retrospective studies (196) 196
analysis (179) 179
survival rate (174) 174
breast neoplasms - diagnosis (173) 173
chemotherapy (171) 171
metastasis (164) 164
women (164) 164
breast neoplasms (161) 161
diseases (160) 160
lymphatic metastasis (158) 158
survival analysis (158) 158
disease-free survival (155) 155
breast neoplasms - therapy (153) 153
follow-up studies (152) 152
care and treatment (148) 148
mammography (148) 148
medicine (148) 148
carcinoma, ductal, breast - mortality (141) 141
breast neoplasms - surgery (140) 140
expression (136) 136
cáncer (127) 127
genetic aspects (127) 127
health aspects (123) 123
carcinoma, ductal, breast - pathology (117) 117
medical prognosis (117) 117
risk (115) 115
abridged index medicus (111) 111
proportional hazards models (111) 111
breast neoplasms - epidemiology (110) 110
treatment outcome (110) 110
neoplasm invasiveness (108) 108
biomarkers, tumor - metabolism (107) 107
breast neoplasms - drug therapy (105) 105
estrogen (105) 105
kaplan-meier estimate (105) 105
mastectomy (104) 104
treatment (103) 103
receptors, estrogen - metabolism (102) 102
gene expression (98) 98
mortality (97) 97
oncology, experimental (95) 95
epidemiology (94) 94
multivariate analysis (94) 94
cancer research (93) 93
age factors (92) 92
male (92) 92
onkologie (92) 92
radiotherapy (92) 92
young adult (92) 92
carcinoma, lobular - mortality (84) 84
receptor, erbb-2 - metabolism (83) 83
radiology, nuclear medicine & medical imaging (81) 81
cohort studies (80) 80
biomarkers, tumor - analysis (79) 79
breast carcinoma (79) 79
cancer patients (79) 79
combined modality therapy (77) 77
neoplasm metastasis (76) 76
breast neoplasms - diagnostic imaging (75) 75
age (74) 74
chemotherapy, adjuvant (74) 74
development and progression (74) 74
receptors, progesterone - metabolism (74) 74
carcinoma, lobular - pathology (73) 73
lymph nodes - pathology (73) 73
mutation (73) 73
breast neoplasms - chemistry (71) 71
methods (71) 71
neoplasm grading (70) 70
predictive value of tests (70) 70
research article (70) 70
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (485) 485
Collection Dvlpm't (Acquisitions) - Closed Orders (33) 33
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Humber River Regional Hospital - Finch Stacks (9) 9
Scarborough Hospital - Birchmount (9) 9
Scarborough Hospital - General (8) 8
St. Michael's Hospital - Stacks (8) 8
UTL at Downsview - May be requested (7) 7
Mt Sinai Hospital - Pathology (6) 6
Dentistry (Harry R Abbott) - Stacks (5) 5
Markham Stouffville Hospital - Stacks (5) 5
Gerstein Science - Circulation Desk (4) 4
Humber River Regional Hospital - Church Stacks (4) 4
Online Resources - Online (4) 4
Dentistry (Harry R Abbott) - Withdrawn (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Providence Healthcare - Stacks (3) 3
St Josephs Health Centre - Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
Providence Healthcare - Reference (2) 2
St. Michael's Hospital - Circulation Desk (2) 2
Women's College Hospital - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Reference (1) 1
Markham Stouffville Hospital - Storage (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Withdrawn (1) 1
Scarborough Hospital - Hospital Department (1) 1
Toronto East General Hospital - Missing (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1746) 1746
Spanish (11) 11
German (7) 7
Polish (2) 2
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2005, Volume 11, Issue 2, pp. 520 - 528
Purpose: The loss of Wnt-5a, a G-protein-coupled receptor ligand, or Syk, an intracellular kinase, has in separate studies been associated with poor prognosis... 
metastasis | cell adhesion | prognostic factors | CELLS | ADHESION | ACTIVATION | INVASION | CYCLIN-E | PROTEIN | ONCOLOGY | TYROSINE KINASE | GROWTH | WNT-5A | BETA-CATENIN | Protein Biosynthesis | Epithelial Cells - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Wnt Proteins | Wnt-5a Protein | Neoplasms, Ductal, Lobular, and Medullary - metabolism | Breast Neoplasms - metabolism | Neoplasm Invasiveness - pathology | Transcription, Genetic | Membrane Proteins - metabolism | Tumor Cells, Cultured | Syk Kinase | Proto-Oncogene Proteins - metabolism | Signal Transduction | Neoplasms, Ductal, Lobular, and Medullary - pathology | Intracellular Signaling Peptides and Proteins | Survival Rate | Discoidin Domain Receptor 1 | Receptor Protein-Tyrosine Kinases - metabolism | Enzyme Precursors - metabolism | Neoplasms, Ductal, Lobular, and Medullary - mortality | Breast Neoplasms - pathology | Cell Adhesion - physiology | Integrin beta Chains - pharmacology | Breast Neoplasms - mortality | Index Medicus | Epithelial Cells/metabolism | Integrin beta Chains/pharmacology | Receptor Protein-Tyrosine Kinases/metabolism | Tumor Cells; Cultured | Proto-Oncogene Proteins/metabolism | Cell Adhesion/physiology | Transcription; Genetic | Enzyme Precursors/metabolism | Neoplasm Invasiveness/pathology | Membrane Proteins/metabolism | Breast Neoplasms/metabolism/mortality/pathology | Neoplasms; Ductal; Lobular; and Medullary/metabolism/mortality/pathology | Protein-Tyrosine Kinases/metabolism
Journal Article
Journal Article
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 09/2005, Volume 35, Issue 9, pp. 514 - 519
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0128368 - e0128368
Background TNBC is an aggressive subset of breast cancer (BC) without specific target therapy. Methods This observational, retrospective study included 45... 
THERAPY | CARCINOGENESIS | MULTIDISCIPLINARY SCIENCES | PROLIFERATION | MUTATIONS | KI67 | IDENTIFICATION | EXPRESSION | CHEMOTHERAPY | LOBULAR CARCINOMA | BASAL | Carcinoma, Ductal, Breast - genetics | Multivariate Analysis | Carcinoma, Lobular - pathology | Prognosis | Cadherins - metabolism | Humans | Middle Aged | Receptors, Androgen - metabolism | Carcinoma, Medullary - diagnosis | Gene Expression Regulation, Neoplastic | Ki-67 Antigen - metabolism | Neoplasm Recurrence, Local - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Neoplasm Recurrence, Local - pathology | Carcinoma, Lobular - genetics | Triple Negative Breast Neoplasms - pathology | Biomarkers, Tumor - metabolism | Adult | Carcinoma, Ductal, Breast - pathology | Female | Retrospective Studies | Cadherins - genetics | Carcinoma, Medullary - mortality | Carcinoma, Medullary - genetics | Carcinoma, Medullary - pathology | Neoplasm Recurrence, Local - diagnosis | Triple Negative Breast Neoplasms - mortality | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | Receptors, Androgen - genetics | Triple Negative Breast Neoplasms - genetics | Ki-67 Antigen - genetics | Triple Negative Breast Neoplasms - diagnosis | Survival Analysis | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Care and treatment | Receptors | Cadherins | Breast cancer | Genetic aspects | Properties | Steroid hormones | Immunohistochemistry | Independent variables | Genes | Oncology | Systematic review | Statistical methods | Metastasis | Paraffin | Multivariate analysis | Cancer therapies | E-cadherin | Subgroups | Proteins | Statistical analysis | Markers | Patients | Molecular chains | Pathology | Androgens | Chemotherapy | Medical prognosis | Mutation | Cancer | Tumors | Index Medicus
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 1/2015, Volume 22, Issue 1, pp. 82 - 89
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 10, pp. 2180 - 2187
Summary Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by poor prognosis. Currently, no reliable markers have been identified... 
Pathology | Ki-67 | Prognosis | ALDH1 | Cox-2 | Breast cancer | Akt | Caspase-3 | Triple-negative breast cancer | Cox-2 Ki-67 | SUBTYPES | PATHOLOGY | WOMEN | IMPACT | EXPRESSION | Receptors, Estrogen - metabolism | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Medullary - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Adenocarcinoma - metabolism | Carcinoma, Lobular - therapy | Carcinoma, Medullary - secondary | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Adenocarcinoma, Mucinous - therapy | Aldehyde Dehydrogenase - metabolism | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | Carcinoma, Medullary - mortality | Neoplasm Recurrence, Local | Survival Rate | Adenocarcinoma, Mucinous - secondary | Combined Modality Therapy | China - epidemiology | Carcinoma, Medullary - therapy | Adenocarcinoma - secondary | Adenocarcinoma, Mucinous - mortality | Carcinoma, Ductal, Breast - therapy | Disease-Free Survival | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Adenocarcinoma, Mucinous - metabolism | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - metabolism | Neoplasm Staging | Adenocarcinoma - mortality | Immunohistochemistry | COX-2 inhibitors | Care and treatment | Analysis | Proteins | Confidence intervals | Chemotherapy | Radiation therapy | Multivariate analysis | Age | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 45 - 51
Abstract This study evaluates the long-term outcomes of a retrospective cohort of breast cancer (BC) patients who had received curatively intended... 
Hematology, Oncology and Palliative Medicine | Pathological complete response | Preoperative radiation therapy | Breast cancer | Triple-negative tumours | Hypofractionated radiation therapy | SURVIVAL | PATHOLOGICAL RESPONSE | TUMOR | RISK | RADIATION-THERAPY | PACLITAXEL | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | RECOMMENDATIONS | POSTMASTECTOMY RADIOTHERAPY | CARCINOMA | Multivariate Analysis | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Prognosis | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Medullary - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Time Factors | Triple Negative Breast Neoplasms - pathology | Mastectomy | Adult | Carcinoma, Ductal, Breast - pathology | Female | Neoadjuvant Therapy | Retrospective Studies | Carcinoma, Medullary - radiotherapy | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Medullary - mortality | Proportional Hazards Models | Carcinoma, Medullary - pathology | Survival Rate | Triple Negative Breast Neoplasms - mortality | Radiotherapy | Disease-Free Survival | Breast Neoplasms - radiotherapy | Carcinoma, Lobular - radiotherapy | Breast Neoplasms - pathology | Triple Negative Breast Neoplasms - metabolism | Carcinoma, Ductal, Breast - radiotherapy | Breast Neoplasms - mortality | Carcinoma, Lobular - metabolism | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Triple Negative Breast Neoplasms - radiotherapy | Cohort Studies | Care and treatment | Cancer patients | Epidemiology | Analysis | Radiation | Health aspects | Phenotypes | Oncology | Radiation therapy | Multivariate analysis | Disease control | Patients | Survival | ErbB-2 protein | Lymph nodes | Confidence intervals | Clavicle | Biopsy | Surgery | Breast | Remission | Skin | Tumors | Cancer | Index Medicus
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2013, Volume 33, Issue 5, pp. 2179 - 2184
Inhibitors of DNA binding (ID) are known to have a role in embryo genesis and oncogenesis. In this study, we analyzed the role of ID1 and ID2 in breast cancer,... 
Helix-loop-helix | ID2 | Inhibitor of differentiation | Cell cycle | ID1 | Breast cancer | qPCR | Inhibitor of DNA binding | cell cycle | PHENOTYPE | breast cancer | inhibitor of DNA binding | CELL LUNG-CANCER | ONCOLOGY | helix-loop-helix | CLINICOPATHOLOGICAL PARAMETERS | GROWTH | PROTEINS | Carcinoma, Ductal, Breast - genetics | Prognosis | Follow-Up Studies | Humans | Carcinoma, Medullary - metabolism | Inhibitor of Differentiation Proteins - genetics | Neoplasm Proteins - metabolism | Breast - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Immunoenzyme Techniques | Breast Neoplasms - metabolism | Adenocarcinoma - metabolism | Neoplasm Grading | Carcinoma, Lobular - genetics | Carcinoma, Medullary - secondary | Inhibitor of Differentiation Protein 2 - genetics | Biomarkers, Tumor - metabolism | Female | Adenocarcinoma - genetics | Neoplasm Proteins - genetics | Breast - pathology | Carcinoma, Ductal, Breast - metabolism | Real-Time Polymerase Chain Reaction | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | Carcinoma, Medullary - mortality | Carcinoma, Medullary - genetics | RNA, Messenger - genetics | Survival Rate | Adenocarcinoma, Mucinous - secondary | Inhibitor of Differentiation Proteins - metabolism | Inhibitor of Differentiation Protein 1 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Inhibitor of Differentiation Protein 2 - metabolism | Adenocarcinoma - secondary | Adenocarcinoma, Mucinous - mortality | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adenocarcinoma, Mucinous - metabolism | Inhibitor of Differentiation Protein 1 - genetics | Breast Neoplasms - mortality | Biomarkers, Tumor - genetics | Carcinoma, Lobular - metabolism | Adenocarcinoma, Mucinous - genetics | Neoplasm Staging | Adenocarcinoma - mortality | Cohort Studies | Index Medicus
Journal Article
Histology and Histopathology, ISSN 0213-3911, 04/2012, Volume 27, Issue 4, pp. 475 - 484
Aberrant sonic hedgehog (SHH)/glioma-associated oncogene (GLI) signaling has been shown in the development of many tumors. The aims of the present study are to... 
FOXC2 | Sonic hedgehog | Gliomaassociated oncogene homolog 1 | Shh | Invasive breast cancers | IBC | Gli1 | Forkhead box C2 | TRIPLE-NEGATIVE PHENOTYPE | TRANSCRIPTION FACTORS | TARGET | ACTIVATION | TGF-BETA | METASTASIS | PATHOLOGY | GLI1 | PROGNOSTIC VALUE | CELL BIOLOGY | SHH | Sonic Hedgehog | Glioma-associated oncogene homolog 1 | CARCINOMA | HEDGEHOG SIGNALING PATHWAY | Carcinoma, Ductal, Breast - genetics | Prognosis | Tissue Array Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoma, Medullary - metabolism | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Neoplasms, Basal Cell - genetics | Adenocarcinoma - metabolism | Cell Nucleus - metabolism | Carcinoma, Lobular - genetics | Carcinoma, Medullary - secondary | Cell Nucleus - pathology | Forkhead Transcription Factors - metabolism | China | Mastectomy | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Ductal, Breast - metabolism | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | Neoplasms, Basal Cell - metabolism | Carcinoma, Medullary - mortality | Carcinoma, Medullary - genetics | Neoplasms, Basal Cell - secondary | Survival Rate | Adenocarcinoma, Mucinous - secondary | Combined Modality Therapy | Transcription Factors - genetics | Forkhead Transcription Factors - genetics | Adenocarcinoma - secondary | Transcription Factors - metabolism | Adenocarcinoma, Mucinous - mortality | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adenocarcinoma, Mucinous - metabolism | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - metabolism | Zinc Finger Protein GLI1 | Adenocarcinoma, Mucinous - genetics | Adenocarcinoma - mortality | Neoplasms, Basal Cell - mortality
Journal Article